Summary
CVS Health Corporation (CVS) filed an 8-K on September 13, 2022, to announce that its senior management team would be participating in a webcast and meeting with investors on September 13, 2022. The primary purpose of this event was to reaffirm the company's previously issued full-year 2022 financial guidance. Specifically, CVS Health reaffirmed its full-year 2022 guidance for Adjusted Earnings Per Share (EPS) to be in the range of $8.40 to $8.60 and its full-year 2022 cash flow from operations to be between $12.5 billion and $13.5 billion. The filing also provided a detailed explanation of their non-GAAP financial measures, particularly Adjusted EPS, clarifying its calculation and purpose for analyzing underlying business performance, while cautioning that it should not be considered a substitute for GAAP measures.
Key Highlights
- 1Reaffirmation of Full Year 2022 Adjusted EPS guidance range of $8.40 to $8.60.
- 2Reaffirmation of Full Year 2022 Cash Flow from Operations guidance range of $12.5 billion to $13.5 billion.
- 3Senior management participated in a webcast and investor meetings on September 13, 2022.
- 4Detailed explanation of the company's use of non-GAAP financial measures, specifically Adjusted EPS.
- 5Explanation that Adjusted EPS excludes items like amortization of intangible assets and other items not related to ordinary course business or underlying performance.
- 6Disclosure that a reconciliation from non-GAAP to GAAP measures is not provided due to the inability to calculate certain adjustments without unreasonable effort.
- 7Standard cautionary language regarding forward-looking statements and non-reliance on them without proper context.